Sofinnova Partners

Key details

Profile type

Organization

Geography

Paris, Unknown / Other, France

Stage

3. Early Revenue, 4. Scaling, 1. Idea or Patent, 2. Prototype, 5. Growth, 6. Pre-IPO

Sector

grid, therapeutic, biodiversity, Sustainable Development Goals, circular economy, mental health, additive manufacturing, mRNA, connected health, cannabis, drug, waste, therapy, sustainable, biomarker, photovoltaic, CO2, renewable, advanced manufacturing, wellbeing, protein, environmental impact, telehealth, lifescience, 3d-printing, industry 4.0, CBD, in vitro diagnostics, smart grids, medical devices, renewables, green tech, metabolites, well-being, smartgrid, genomics, manufacturing, cell therapy, robotics, industrial revolution, therapeutics, life science, biomarkers, solar, bio, diagnostics, life sciences, longevity, wind, biopharma, greentech, biotech, sustainability, environmental, utilities, SDG, climate, proteomics, life sciences tools, ehealth, health, smart grid, pharma, gene therapy, industrial, healthcare, digital-health, transcriptomics, tech-enabled health, bioimaging, psychedelics, industry 4, environment, renewable energy, water, medtech, healthier living, smart factory, pharmaceuticals, medical device, medicines, US SDG, life-science, clean energy, drugs, med device, health-tech, lifesciences, smartgrids, recycling, 3d printing, CGT, healthtech, metabolomics, industrial IoT, environnement, clean tech, ESG, IVD, IIoT, smart manufacturing, wellness, e-health, cleantech, connected-health, psychedelic

Invests in

["France","Italy","USA","Germany","Netherlands","Canada","Switzerland","UK"]

Investment size

$1M to $60M

Founder groups

Not publicly stated